Identification of Potential HLA-A *0201 Restricted CTL Epitopes Derived from the Epithelial Cell Adhesion Molecule (Ep-CAM) and the Carcinoembryonic Antigen (CEA)-Reference-Cited by-同舟云学术

Identification of Potential HLA-A *0201 Restricted CTL Epitopes Derived from the Epithelial Cell Adhesion Molecule (Ep-CAM) and the Carcinoembryonic Antigen (CEA)

Published:1997-03 Issue:1 Volume:53 Page:81-89
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Ras Elisabeth,van der Burg Sjoerd H,Zegveld Suzanne T,Brandt Remco M.P.,Kuppen Peter J.K.,Offringa Rienk,Warnarr Sven O.,van de Velde Cornells J.H.,Melief Cornelis J.M.

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference39 articles.

1. Ep-CAM: A human epithelial antigen is a ho-mophilic cell-cell adhesion molecule;Litvinov;J Cell Biol,1994

2. Colo-rectal carcinoma-specific antigen: detection by means of monoclonal antibodies;Herlyn,1979

3. Colorectal carcinoma antigens detected by hybridoma antibodies;Koprowski;Som Cell Gen,1979

4. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques;Gold;J Exp Med,1965

5. Monoclonal antibody identification and characterization of a Mr 43 000 mem-brane glycoprotein associated with human breast cancer;Edwards;Cancer Res,1986

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms;Pharmaceutics;2022-07-11

2. The Ad5 [E1-, E2b-]-based vector: a new and versatile gene delivery platform;Advances in Global Health through Sensing Technologies 2015;2015-05-13

3. A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer;Annals of Surgery;2013-12

4. Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial;Journal of the American College of Surgeons;2010-02

5. A Novel Mouse Model for Evaluation and Prediction of HLA-A2-restricted CEA Cancer Vaccine Responses;Journal of Immunotherapy;2009-09